Flower, M., Lomeikaite, V., Ciosi, M., Cumming, S., Morales Montero, F., Lo, K., . . . Tabrizi, S. J. (2019). MSH3 modifies somatic instability and disease severity in Huntington’s and myotonic dystrophy type 1.
استشهاد بنمط شيكاغوFlower, Michael, et al. MSH3 Modifies Somatic Instability and Disease Severity in Huntington’s and Myotonic Dystrophy Type 1. 2019.
MLA استشهادFlower, Michael, et al. MSH3 Modifies Somatic Instability and Disease Severity in Huntington’s and Myotonic Dystrophy Type 1. 2019.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.